Skip to main content
European Commission logo
polski polski
CORDIS - Wyniki badań wspieranych przez UE
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary
Zawartość zarchiwizowana w dniu 2024-06-18

Incorporating protein backbone flexibility and induced-fit in drug discovery

Cel

The activity of many proteins, strongly changes when small ligands dock into well defined cavities of the protein receptor. For proteins involved in disease-related metabolic pathways novel artificial ligands may act as drugs. In the drug discovery process, high-throughput in-silico screening(IS-HTS) methods are increasingly used to identify lead compounds, i.e. ligands that bind to a target protein with high affinity. Existing methods have significant shortcomings, because the time spent on each ligand is very short. In an ongoing collaboration with the Barcelona Supercomputer Center (BSC) I implemented FlexScreen, the IS-HTS program developed by the host group at FZK, on the Cell, a new processor developed by BSC and IBM into the next generation of ultra-fast peta-flop supercomputers. The individual processing unit of these new computers is distributed separately and delivers about 250 times the performance of a PC at roughly the same cost. In the mobility project I will exploit this unprecedented computational power to incorporate new ideas into the IS-HTS method, not achievable with standard computational hardware. Continuing the collaboration with BSC I will develop improved biophysical scoring functions and novel docking strategies. I will also address a long-standing problem of IS-HTS methods: the change of protein conformation upon binding (induced fit). In collaboration with the cancer research center in Heidelberg (DKFZ) I will apply these new methods to search for new lead compounds to DNA-methyl-transferases to develop new therapies for cancer. The results of this research will reduce the time and cost of the initial stages of drug design, not only in academic but also for industrial projects, increasing the competitiveness of the European pharmaceutical industry. They will improve the quality of life of the European population by helping to discover new drug molecular scaffolds, addressing one of the main problems of present-day drug development.

Zaproszenie do składania wniosków

FP7-PEOPLE-2007-2-1-IEF
Zobacz inne projekty w ramach tego zaproszenia

Koordynator

KARLSRUHER INSTITUT FUER TECHNOLOGIE
Wkład UE
€ 159 828,87
Adres
KAISERSTRASSE 12
76131 Karlsruhe
Niemcy

Zobacz na mapie

Region
Baden-Württemberg Karlsruhe Karlsruhe, Stadtkreis
Rodzaj działalności
Higher or Secondary Education Establishments
Kontakt administracyjny
Natascha Wallburg (Ms.)
Linki
Koszt całkowity
Brak danych